The Research
The evidence behind the Rinnovare Light™, in the open: 1,227 PubMed records screened, 47 studies curated — 18 randomized controlled trials, 14 systematic reviews and meta-analyses — and every reference on this page linked to its source.
The strongest results, with numbers
Randomized, controlled, sham-comparing — the studies we lead with because they are the ones that would survive scrutiny.
Periocular wrinkle volume −31.6%
Split-face randomized controlled trial, 660 nm, ten sessions over four weeks at 3.8 J/cm². Wrinkle volume fell by roughly a third — the strongest facial-rejuvenation result in the literature.
Photobiomodul Photomed Laser Surg · 2023 →Collagen density, measurably up
Controlled trial, 30 sessions at ~9 J/cm²: improved complexion and skin roughness with increased intradermal collagen density on ultrasound — the classic red + near-infrared result.
Wunsch & Matuschka · Photomed Laser Surg 2014 →Home device beats sham
Multicentre double-blind sham-controlled RCT (Fitzpatrick II–V): a 630 + 850 nm home mask improved crow’s-feet grading versus sham — evidence in exactly the at-home format.
Medicine · 2025 →Twelve weeks, visible change
Randomized double-blind: daily 660 nm sessions over 12 weeks significantly improved periocular wrinkle replicas.
Nam et al. · Dermatol Surg 2017 →Muscle performance, quantified
Pre-exercise phototherapy added +4.12 s to time-to-exhaustion and +5.47 repetitions across 13 good-quality RCTs.
Leal-Junior et al. · Lasers Med Sci 2015 →Safety with wide margins
Two dose-escalation trials: LED red light tolerated up to 320 J/cm² in skin of colour and 480 J/cm² in Caucasian skin — orders of magnitude above any home session.
Jagdeo et al. · J Biophotonics 2020 →What each wavelength’s evidence actually shows
Honest readings — including where evidence is strong, where it is weaker, and where we deliberately make no treatment claim.
Surface glow and deep renewal
The best-supported use of red light. Trials show ~30% periocular wrinkle-volume reduction, improved complexion and collagen density; head-to-head, no single red wavelength has beaten another — consistency of use is what the trials reward.
PMIDs 36780572 · 24286286 · 28195844 →Muscle and joint recovery
Meta-analytic support for pre-exercise phototherapy across 13–24 RCTs (strength, soreness, creatine kinase). Honest reading: benefits concentrate in laser arms; LED evidence is weaker but positive in the home-mask format.
PMIDs 24249354 · 34428975 · 27272746 →Warmth and comfort
940 nm sits in a water-absorption band: the sensation is gentle, superficial warmth — a comfort feature for evening sessions, and we present it as exactly that.
Mechanism: water-absorption band · dosimetry reviews →The morning signal
Blue light reliably entrains the circadian system and lifts alertness — through the eyes. The measured melatonin-suppression peak is ~485 nm, with 460 nm well inside the responsive window. If you have melasma or pigmentation concerns, skip facial blue sessions — blue light can worsen pigmentation in darker skin tones.
PMIDs 36051910 · 38241677 · 32478879 →How light does it, and why dose decides
Five decades of photobiomodulation science — and the dosimetry discipline that separates the trials that worked from those that didn’t.
Cytochrome-c oxidase — the engine
Red and near-infrared photons are absorbed by cytochrome-c oxidase in the mitochondrial respiratory chain, lifting ATP output and switching on repair signalling. Five decades of literature; not fringe.
Avci 2013 · Chung 2012 →The biphasic response
Too little does nothing; the right amount stimulates; too much can blunt the effect. Effective trials cluster at ~4–10 J/cm² per session — the reason the Light builds dosing into its guided programs and 3-minute timer.
Huang 2009 · Zein (Hamblin group) 2018 →Why we publish our protocol
A review of 74 PBM papers found 73% reported no light-measurement method. A 2025 bench study of home torches measured 74° beam divergence and unstable output — hold distance and dwell time decide your dose. We state ours.
Hadis 2016 · Cronshaw 2025 →Read this before your first session
The safety literature is broadly reassuring — with three specific caveats we state plainly.
No oncologic signal
A systematic review of clinical and preclinical evidence found photobiomodulation within established parameters does not induce dysplasia and shows no adverse oncologic signal.
Glass · Aesthet Surg J 2023 →Know your skin
Dose-escalation trials established wide safety margins — and that darker skin is more photosensitive, not less. Blue (460 nm) facial sessions carry a hyperpigmentation risk for melasma-prone and Fitzpatrick III+ skin.
Jagdeo 2020 · Campiche 2020 →Never aim at the eyes
The near-infrared emitters are invisible and trigger no blink reflex; blue light carries retinal phototoxicity risk. Repeated low-level red light shows a mostly reassuring 3-year eye-safety record — with isolated OCT changes reported. Eye protection is the reasonable standard.
Chakravarthy 2024 · Chen 2026 →How this library was built
20 structured PubMed queries plus 18 targeted follow-ups returned 1,227 unique records. From these, 47 studies were curated — 18 randomized controlled trials, 14 systematic reviews or meta-analyses, 15 mechanistic, dosimetric or regulatory sources — each annotated to the product claim it bears on. Regulatory status was checked against the openFDA 510(k) database. Citations were verified against the source papers; where a study’s finding is a null result, it is listed as one.
The Rinnovare Light™ is a wellness device and is not intended to diagnose, treat, cure or prevent any disease. Study results were obtained under the protocols described, which may differ from at-home use. This page is informational and is not medical advice.
38 studies, every one linked
The complete curated reference list behind this page and our manual — trial design, finding, journal, PubMed ID. Click any row’s reference to read the abstract yourself.
| # | Study | Finding | Journal · PubMed |
|---|---|---|---|
| 1 | Mota et al. 2023 · RCT · n=137 | Split-face RCT, 660 nm ×10 sessions: periocular wrinkle volume −31.6%; amber 590 nm nearly matched. | Photobiomodul Photomed Laser Surg · PMID 36780572 |
| 2 | Wunsch & Matuschka 2014 · RCT · n=136 | 30 sessions ~9 J/cm²: improved complexion, roughness; increased ultrasound collagen density. | Photomed Laser Surg · PMID 24286286 |
| 3 | Park et al. 2025 · Sham RCT · n=60 | 630 + 850 nm home mask improved crow’s-feet grading vs sham (Fitzpatrick II–V). | Medicine (Baltimore) · PMID 39960921 |
| 4 | Nam et al. 2017 · RCT · n=52 | 12 weeks daily 660 nm improved periocular wrinkle replicas; broad-spectrum LED matched it. | Dermatol Surg · PMID 28195844 |
| 5 | Bragato et al. 2025 · Sham RCT · n=95 | 660 nm mask, 8.05 J/cm²: no Wrinkle Assessment Scale difference vs sham — an honest null. | Lasers Med Sci · PMID 40167796 |
| 6 | Weiss et al. 2005 · RCT | LED array at just 0.1 J/cm² per session improved photoaging measures — very low doses are not inert. | Lasers Surg Med · PMID 15654716 |
| 7 | Goldberg et al. 2006 · RCT | Combined 633 + 830 nm LED treatment improved photoaging skin on blinded assessment. | J Drugs Dermatol · PMID 16989189 |
| 8 | Kwon et al. 2013 · RCT | Home-use blue+red LED, 2.5 min twice daily: 77% reduction in inflammatory acne lesions. | Br J Dermatol · PMID 23278295 |
| 9 | Castanedo-Cazares 2014 · RCT · n=68 | Iron-oxide (visible-light) sunscreen beat UV-only for melasma by 15% — visible light drives pigmentation. | Photodermatol Photoimmunol Photomed · PMID 24313385 |
| 10 | Campiche et al. 2020 · RCT · n=33 | Repeated 450 nm blue light (4×60 J/cm²) produced measurable hyperpigmentation in Fitzpatrick III–IV skin. | Int J Cosmet Sci · PMID 32478879 |
| 11 | Li et al. 2022 · RCT | Red light matched or beat blue for acne (36.2% vs 30.7% lesion improvement) with fewer adverse reactions. | Photodermatol Photoimmunol Photomed · PMID 34981580 |
| 12 | Jagdeo et al. 2020 · Phase I RCTs · n=115 | LED red light safe to 320 J/cm² (skin of colour) / 480 J/cm² (Caucasian); darker skin more photosensitive. | J Biophotonics · PMID 31483941 |
| 13 | Chen et al. 2026 · 3-year RCT · n=362 | Repeated low-level red light (myopia control): no vision loss; minimal reversible OCT changes in 4 eyes. | Br J Ophthalmol · PMID 41558834 |
| 14 | Leal-Junior et al. 2015 · Meta · 13 RCTs | Pre-exercise phototherapy: +4.12 s time-to-exhaustion, +5.47 repetitions. | Lasers Med Sci · PMID 24249354 |
| 15 | Luo et al. 2022 · Meta · 24 RCTs | Athletes: improved lower-limb strength, reduced soreness, creatine kinase and IL-6. | Sports Health · PMID 34428975 |
| 16 | Nampo et al. 2016 · Meta-analysis | Benefits concentrated in laser arms; LED-only analyses showed no significant between-group difference. | Lasers Med Sci · PMID 27272746 |
| 17 | Vanin et al. 2018 · Review · 39 trials | Muscle PBM evidence rated very low–moderate quality; small samples, heterogeneous parameters. | Lasers Med Sci · PMID 29090398 |
| 18 | Álvarez-Martínez 2025 · Sys review · 5 studies | Whole-body PBM: no benefit for exercise performance or fatigue biomarkers. | Lasers Med Sci · PMID 39883205 |
| 19 | Barbaric et al. 2018 · Cochrane · 71 RCTs | Light therapies for acne: most comparisons showed no clinically significant difference; adverse-event reporting poor. | Br J Dermatol · PMID 28338214 |
| 20 | Scott et al. 2019 · Meta · 14 trials | Blue light for acne: no significant difference vs comparators for lesion counts. | Ann Fam Med · PMID 31712293 |
| 21 | Chauhan et al. 2021 · Systematic review | Multiple visible wavelengths alter melanocyte behaviour — visible light matters in pigmentation. | Photochem Photobiol · PMID 33987856 |
| 22 | Silvani et al. 2022 · Systematic review | Blue light (ocular) increased alertness in most studies; cognitive performance in over half. | Front Physiol · PMID 36051910 |
| 23 | Glass 2023 · Systematic review | No adverse oncologic signal for PBM within established parameters. | Aesthet Surg J · PMID 36722207 |
| 24 | Hadis et al. 2016 · Sys review · 74 papers | 73% of PBM studies reported no light-measurement method — dose reporting is the field’s weak spot. | Lasers Med Sci · PMID 26964800 |
| 25 | Avci et al. 2013 · Review | Landmark review of low-level light therapy in skin: stimulating, healing, restoring. | Semin Cutan Med Surg · PMID 24049929 |
| 26 | Chung et al. 2012 · Review | Definitive review of LLLT mechanisms and dosimetry — the nuts and bolts. | Ann Biomed Eng · PMID 22045511 |
| 27 | Huang et al. 2009 · Review | The biphasic dose response: too little does nothing; too much can blunt the effect. | Dose Response · PMID 20011653 |
| 28 | Zein et al. 2018 · Review | Hamblin-group parameter review: effective window ~4–10 J/cm² at <100 mW/cm²; skin needs more light than muscle. | J Biomed Opt · PMID 30550048 |
| 29 | Austin et al. 2021 · Mechanistic · RNA-seq | Red light upregulates MMP1 (collagen remodelling) alongside anti-fibrotic PRSS35 — remodelling, not a simple switch. | Sci Rep · PMID 33795767 |
| 30 | Mamalis et al. 2015 · In vitro | At high fluences (240–480 J/cm²) red light inhibited fibroblast proliferation — dose decides direction. | Dermatol Surg · PMID 25485805 |
| 31 | Mamalis et al. 2015 · In vitro | Blue light modulates fibroblast characteristics dose-dependently (5–80 J/cm²). | Lasers Surg Med · PMID 25655579 |
| 32 | Brown 2021 · Human study | S-cone contribution to melatonin suppression at 415 nm — the eye’s blue response is multi-receptor. | J Pineal Res · PMID 33512714 |
| 33 | Najjar et al. 2024 · Human study | Melatonin-suppression peak 485.3 nm in young adults, ~500 nm in older adults — 460 nm inside the window. | J Pineal Res · PMID 38241677 |
| 34 | Andrabi et al. 2023 · Review | Nonvisual opsins (OPN3/OPN5): extraocular light sensing established in mice, emerging in humans. | Annu Rev Vis Sci · PMID 37196422 |
| 35 | Pourang et al. 2022 · Review | Visible light contributes to skin photoaging mechanisms — protection matters. | Photodermatol Photoimmunol Photomed · PMID 34585779 |
| 36 | Chakravarthy et al. 2024 · Review | Blue-light retinal phototoxicity: oxidative stress, lipofuscin accumulation, mitochondrial dysfunction. | Front Aging Neurosci · PMID 39741521 |
| 37 | Cronshaw et al. 2025 · Bench study | Five home LED torches: 74° beam divergence, unstable output, dosing instructions inconsistent with delivery. | Dent J (Basel) · PMID 39996950 |
| 38 | Zhang et al. 2025 · Case report | Structural OCT changes after repeated low-level red light — one reason we say never aim at the eyes. | JAMA Ophthalmol · PMID 40839279 |
Photobiomodulation literature, curated 2026. Abstracts via PubMed; full papers via each journal. The Rinnovare Light™ is a wellness device and is not intended to diagnose, treat, cure or prevent any disease.
